Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0002-9378(66)90557-6 | DOI Listing |
Cureus
July 2024
Radiodiagnosis, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, Pune, IND.
BMC Cancer
May 2024
Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Erqi District, Zhengzhou, Henan, 450052, PR China.
Background: Neuroendocrine carcinoma (NEC) originating from the endometrium is rare, and there is limited knowledge regarding its diagnosis and optimal management. In this study, we present our experience with 11 patients with endometrial NEC, aiming to provide guidance for clinical practice.
Methods: We retrospectively collected the clinical, pathological, and treatment data of 11 patients with endometrial NEC who were treated at the First Affiliated Hospital of Zhengzhou University from January 2011 to July 2023.
Asian J Surg
March 2024
Department of Obstetrics and Gynecology, Shunde Women and Children's Hospital of Guangdong Medical University (Maternity & Child Healthcare Hospital of Shunde Foshan), No. 3 Health Care Road, Daliang Street, Shunde District, Foshan, 528300, Guangdong Province, China. Electronic address:
Int J Gynecol Cancer
November 2024
Pathology (Histopathology Division), Sir Ganga Ram Hospital, New Delhi, Delhi, India
Case Rep Oncol
November 2023
Department of Obstetrics and Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Introduction: Histologically, endometrial neuroendocrine carcinoma is an extremely rare pathological type of endometrial cancer. In addition, this type is characterized by high invasiveness and poor clinical outcome, which was classified into carcinoid (low grade), and small-cell and large-cell neuroendocrine carcinoma (high grade). Globally, reports on endometrial carcinoid carcinoma are limited.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!